Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake

Journal of Nuclear Cardiology

Volumn 19, Issue 1, 2012, Pages 92-99

  Chen, Ji ^a   Folks, Russell D ^a   Verdes, Liudmila ^a   Manatunga, Daya N ^a   Jacobson, Arnold F ^b   Garcia, Ernest V ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

Heart failure; I 123 mIBG; SPECT; Sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; ALGORITHM; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART TO MEDIASTINUM RATIO; HUMAN; IMAGE RECONSTRUCTION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; HEART; HEART MUSCLE; METABOLISM; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING; TISSUE DISTRIBUTION;

3-IODOBENZYLGUANIDINE; AGED; ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART; HEART FAILURE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MYOCARDIUM; PILOT PROJECTS; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84861524418     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9438-0     Document Type: Article

References (23)

1. Henneman MM, Bengel FM, van der Wall EE, Knuuti J, Bax JJ. Cardiac neuronal imaging: Application in the evaluation of cardiac disease. J Nucl Cardiol 2008;15:442-55.
2. Merlet P, Benvenuti C, Moyse D, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999; 40:917-23. (Pubitemid 29269210)
3. Fujimoto S, Inoue A, Hisatake S, et al. Usefulness of 123Imetaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of beta-blockers in patients with dilated cardiomyopathy from the stand-point of long-term prognosis. Eur J Nucl Med Mol Imaging 2004;31:1356-61. (Pubitemid 39361930)
4. Nakata T, Wakabayashi T, Kyuma M, et al. Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure. Eur J Nucl Med Mol Imaging 2005;32:186-94. (Pubitemid 40248490)
5. Anastasiou-Nana MI, Terrovitis JV, Athanasoulis T, et al. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2005;96:427-31. (Pubitemid 41058876)
6. Arimoto T, Takeishi Y, Niizeki T, et al. Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure. J Card Fail 2007;13:34-41. (Pubitemid 46330832)
7. Kioka H, Yamada T, Mine T, et al. Prediction of sudden death by using cardiac iodine-123 metaiodobenzylguanidine imaging in patients with mid to moderate chronic heart failure. Heart 2007; 93:1213-8. (Pubitemid 47492905)
8. Kasama S, Toyama T, Kumakura H, et al. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol 2003;41:574-81. (Pubitemid 36223322)
9. Kasama S, Toyama T, Hatori T, et al. Evaluation of cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy on the treatment containing carvedilol. Eur Heart J 2007;28:989-95. (Pubitemid 47343912)
10. Kakuchi H, Sasaki T, Ishida Y, Komamura K, Miyatake K. Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment. Heart 1999;81:148-52. (Pubitemid 29119388)
11. Gould PA, Kong G, Kalff V, et al. Improvement in cardiac adrenergic function post biventricular pacing for heart failure. Europace 2007;9:751-6. (Pubitemid 47371648)
12. Wakabayashi T, Nakata T, Hashimoto A, et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 2001; 42:1757-67. (Pubitemid 34016342)
13. Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7.
14. Cohen-Solal A, Esanu Y, Logeart D, et al. Cardiac metaiodobenzyl- guanidine uptake in patients with moderate chronic heart failure: Relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999;33:759-66.
15. Nakata T, Miyamoto K, Doi A, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998;5: 579-90. (Pubitemid 29015414)
16. Kasama S, Toyama T, Kumakura H, et al. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. J Nucl Med 2002;43:1279-85.
17. Agostini D, Belin A, Amar MH, et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy:A 123I-MIBG scintigraphic study. J Nucl Med 2000;41:845-51. (Pubitemid 30266029)
18. Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine- 123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF study. J Am Coll Cardiol 2010;55:2212-21.
19. BoogersMJ, Borleffs CJ, HennemanMM, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverterdefibrillator patients. J Am Coll Cardiol 2010;55:2767-77.
20. Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol 2006;13:251-60.
21. Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Improved quantification in I-123 cardiac SPECT imaging with deconvolution of septal penetration. Nucl Med Commun 2006;27:551-8. (Pubitemid 44305310)
22. Jacobson AF, Lombard J, Banerjee G, Camici P. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials. J Nucl Cardiol 2009;16:113-21.
23. Somsen GA, Borm JJ, de Milliano PA, et al. Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: A new approach using the left ventricular cavity and a blood sample as a reference. Eur J Nucl Med 1995;22:1149-54.